The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms

Area of Science:

• Cardiology
• Endocrinology
• Molecular Medicine

Background:

• Diabetes mellitus (DM) is associated with a higher incidence and poorer prognosis of heart failure (HF).
• This increased risk persists even without other traditional cardiovascular risk factors.
• Diabetic cardiomyopathy (DM-CMP) is proposed as a key underlying mechanism linking DM and HF.

Purpose of the Study:

• To review the major pathophysiological changes in diabetic cardiomyopathy (DM-CMP).
• To outline the underlying molecular and cellular mechanisms contributing to myocardial remodeling in DM-CMP.
• To explain how these mechanisms lead to cardiac functional derangement in diabetic individuals.

Main Methods:

• This is a review article, synthesizing current research on diabetic cardiomyopathy.
• It examines systemic, myocardial, and cellular/molecular mechanisms.
• Focuses on metabolic, oxidative, inflammatory, and epigenetic factors.

Main Results:

• Metabolic abnormalities (lipotoxicity, glucotoxicity), mitochondrial dysfunction, oxidative stress, and inflammation are key contributors.
• These factors promote extracellular remodeling and hypertrophy of the heart.
• The process ultimately leads to impaired left ventricular diastolic and systolic function.

Conclusions:

• Diabetic cardiomyopathy is a complex condition driven by multiple interacting pathophysiological pathways.
• Understanding these mechanisms is crucial for developing targeted therapies for heart failure in diabetic patients.
• Further research is needed to fully elucidate the intricate interplay of factors involved in DM-CMP.